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Heparan sulphateThe mechanisms behind target vs. host cell recognition of the human antimicrobial peptide LL-37 remain ill-
deﬁned. Here, we have investigated the membrane disruption capacity of LL-37 using large unilamellar
vesicles (LUVs) composed of varying mixtures of POPC, POPG and cholesterol to mimic target and host
membranes respectively. We show that LL-37 is unable to induce leakage of entrapped calcein from
zwitterionic POPC LUVs, whereas leakage from LUVs partially composed of POPG is fast and efﬁcient. In
accordance with typical antimicrobial peptide behavior, cholesterol diminished LL-37 induced leakage. By
using linear dichroism and ﬂow oriented LUVs, we found that LL-37 orients with the axis of its induced α-
helix parallel to the membrane surface in POPC:POPG (7:3) LUVs. In the same system, we also observed a
time-dependent increase of the parallel α-helix LD signal on timescales corresponding to the leakage
kinetics. The increased LD may be connected to a peptide translocation step, giving rise to mass balance
across the membrane. This could end the leakage process before it is complete, similar to what we have
observed. Confocal microscopy studies of eukaryotic cells show that LL-37 is able to mediate the cell delivery
of non-covalently linked ﬂuorescent oligonucleotides, in agreement with earlier studies on delivery of
plasmid DNA (Sandgren et al., J. Biol. Chem. 279 (2004) 17951). These observations highlight the potential
dual functions of LL-37 as an antimicrobial agent against bacterial target cells and a cell-penetrating peptide
that can deliver nucleic acids into the host cells.R, Attenuated Total Reﬂection
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The rapid development of bacterial resistance to conventional
antibiotics is becoming an increasingly difﬁcult problem that
necessitates the development of new strategies to combat microbialinfection. Naturally derived antimicrobial peptides (AMPs) commonly
display potent broad spectrum bactericidal activities in combination
with a reasonably high selectivity, rendering these macromolecules
interesting as model compounds for the development of the next
generation antibiotics. In contrast to conventional antibiotics which
exert toxic activity by binding to speciﬁc targets, AMPs have
classically been considered to act by more non-speciﬁc membrane-
destabilizing mechanisms. The basis of their selectivity is thought to
rely on preferential binding to the negatively charged outer leaﬂet of
bacterial plasma membranes of microbes as compared to the
predominantly zwitterionic outer leaﬂet of the eukaryotic plasma
membrane [1]. Hallmarks for AMPs are a net positive charge and
ability to adopt amphipathic secondary structures upon interaction
with lipid bilayers. The latter has been suggested as crucial for the
peptide-induced permeabilization of the target membrane [1,2].
LL-37 is, to this date, the only AMP identiﬁed in the human
cathelicidin family. It is a 37 residue peptide (LLGDF5 FRKSK10 EKIGK15
EFKRI20 VQRIK25 DFLRN30 LVPRT35 ES) that carries 16 charged
residues in total. At neutral pH, its net charge is +6 [3]. LL-37 is a
proteolytic cleavage product corresponding to the C-terminus of its
precursor protein hCAP18 (human cationic antibacterial protein of
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of cell types throughout the human body — consequently being
present in several tissues and body ﬂuids [7]. Thus, LL-37 has
potentially important roles that go beyond its antibiotic activity and
hCAP18/LL-37 expression has been found to be either up- or down-
regulated in various conditions of disease, implying that LL-37 is also a
part of the human innate immune response [8,9].
LL-37 displays antimicrobial activity against both Gram-positive
and Gram-negative bacteria at a minimum inhibitory concentration
(MIC) in the b10 μg/ml range [10]. Electron micrographs of stained
E. coli show that LL-37 causes morphological changes to the cell
membranes below MIC and full lysis when MIC is reached [3]. In
addition, freeze-fracture electron microscopy studies of Candida albi-
cans cells subjected to MIC concentrations of LL-37 show disintegra-
tion of the cells into discrete vesicles with a concomitant efﬂux of cell
material [11]. Therefore, it is likely that peptide-induced membrane
disruption is directly involved in the antimicrobial action of LL-37.
LL-37 has been well characterized with respect to antimicrobial
activity, in vivo expression and immunomodulatory function (see
Dürr et al. [7] for an extensive review). Its biophysical properties,
particularly in model membrane systems designed to mimic prokary-
otic and eukaryotic membranes, have also been examined. It has been
found that LL-37 is most effective in killing bacteria under conditions
where the propensity for α-helix formation is high, and that helix
formation is facilitated by the ability of certain ions to “salt out”
nonpolar groups in LL-37 [12].
Regarding membrane binding, the reports about the ability of LL-
37 to discriminate between zwitterionic and negatively charged lipids
are still somewhat ambiguous. LL-37 can interact with both
zwitterionic and net negatively charged lipid vesicles, adopting
predominantly α-helical structures [3,13]. The structure of LL-37 in
complex with membrane-mimetic SDS and DPC micelles has been
assessed [14,15]. However, at least two groups report that there is no
interaction between LL-37 and zwitterionic lipid monolayers [16,17].
There are also some indications that LL-37 membrane interactions are
not entirely governed by electrostatics. Other membrane character-
istics, such as acyl chain packing andmembrane rigidity (introduction
of sterols) and dynamics have been suggested to have a decisive role
on membrane–peptide interactions. Polarized ATR-FTIR spectroscopy
[3] as well as solid-state NMR [18] suggests that LL-37 is mainly
oriented parallel to the lipid surface.
It has been reported that LL-37 causes membrane leakage of small
ions (dissipation of potassium gradients over lipid vesicle mem-
branes) in both zwitterionic and negatively charged large unilamellar
vesicles, indicating that LL-37 is not able to selectively disrupt
bacterial membranes [13,17,19]. On the other hand, the results of
Björstad et al. [20] indicate at least some discrimination in the level of
calcein leakage between phospholipid vesicles with compositions
mimicking prokaryotic and eukaryotic cell membranes. It has been
suggested that LL-37 causes membrane disruption and subsequent
leakage via a detergent-like carpeting mechanism [3,18].
In the present study we systematically explore the leakage-
inducing activity of LL-37 in unilamellar phospholipid vesicles (LUVs)
with varied contents of zwitterionic (POPC) and negatively charged
(POPG) phospholipids, in the absence and presence of cholesterol.
LUVs are considered to be good and rather stable mimetic systems for
cell membranes, particularly for bacteria, because of their size
(typically 100 nm in diameter) which is not too far from that of a
bacterial cell. LUVs have a moderate curvature and relatively large
inner volume compared to small unilamellar vesicles (SUVs) which
have a diameter of usually less than 50 nm. In LUVs, peptides are
expected to be less affected by the tension in the membrane imposed
by curvature, but for spectroscopic measurements SUVs are some-
times preferred because they cause less light scattering. Giant
unilamellar vesicles (GUVs) with a diameter of about 10 μM have a
size on the scale of eukaryotic cells, but they give rise to lightscattering. Here we have chosen to use LUVs as membrane mimetics,
which combine relatively good stability with manageable light
scattering problems [21,22]. Our results provide evidence of a so-
called graded mechanism of vesicle leakage in the partly negatively
charged vesicles. The vesicle binding geometry is studied by means of
polarized light absorption spectroscopy (linear dichroism) on α-
helical LL-37 associated with shear-aligned LUVs. In view of the
ongoing discussion about the sometimes converging roles of AMPs
and CPPs (cell-penetrating peptides) [23], we also studied the CPP
properties of LL-37, and show that LL-37mediates the translocation of
a non-covalently complexed oligonucleotide into live eukaryotic cells.
2. Materials and methods
2.1. Materials
LL-37 was synthesized by Innovagen AB (Lund, Sweden). Peptide
sequence and purity (N98%) were conﬁrmed by reverse phase HPLC
and mass spectrometry. The peptide concentration was determined
by quantitative amino acid analysis (hydrolysis by acid treatment
followed by quantiﬁcation of the amino acid content by liquid
chromatography). 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphatidyl-
choline (POPC), 1-Palmitoyl-2-oleoyl-sn-glycero-phosphoglycerol
(POPG), and cholesterol were purchased from Avanti Polar Lipids
(Alabaster, US). 1,6-diphenyl-1,3,5-hexatriene (DPH) was obtained
from Sigma-Aldrich (Sweden). Calcein was from Fluka Biochemica
(Buchs, Schweiz). Heparan sulphate (HS) (estimated MW ∼15 kDa;
each HS molecule carries about 65 negative charges) was prepared as
described previously [24]. The YOYO-1 label was acquired from
Molecular Probes and the DNA-ON from Sigma.
2.2. Preparation of large unilamellar vesicles (LUVs)
LUVs were prepared by dissolving phospholipids and cholesterol in
chloroform at desired molar ratios to ensure complete mixing of the
components. The solvent was removed under a stream of nitrogen and
the dried lipid ﬁlm was thereafter dispersed in buffer (50 mM
phosphate buffer, pH 7.4 unless stated otherwise). To obtain monodis-
perse, unilamellar vesicles, the dispersion was freeze-thawn six times
and then extruded through two polycarbonate ﬁlters (100 nm pore
size) 21 times using a manual extruder from Avanti (Alabaster, US).
2.3. Fluorescence spectroscopy
Fluorescence was measured on a Perkin Elmer LS 50B Lumines-
cence Spectrometer interfaced with the FL WinLab software. For the
calcein leakage experiments (vide infra) the excitation monochroma-
tor was set to 490 nm and the emission was scanned from 500 to
540 nm, with a bandwidth of 3 nm for both excitation and emission.
Five consecutive scans, recorded at a scan speed of 250 nm/min, were
accumulated and averaged for each data point. The temperature was
set to 20 °C and a 4×10 mm quartz cuvette was used.
For the DPH ﬂuorescence polarization experiments the excitation
monochromator was set to 355 nm and the emission was recorded at
530 nm. Fluorescence measurements were conducted at 37 °C using
the same cuvette and spectra collection method as described for the
calcein leakagemeasurements. A polarization attachment (Shimadzu)
was adapted to the spectrometer allowing the steady-state polariza-
tion to be determined using the following equation:
P =
IVV−GIVH
IVV + GIVH
; G =
IHV
IHH
ð1Þ
where IVV is the emission intensity recorded with vertically polarized
excitation and emission and IVH is the emission intensity recorded
with vertically polarized excitation and horizontally polarized
2203X. Zhang et al. / Biochimica et Biophysica Acta 1798 (2010) 2201–2208emission. The instrumental correction factor G was determined by
measuring the polarized components of ﬂuorescence of the probe
with horizontally polarized excitation.
2.4. Calcein leakage from LUVs induced by LL-37
LUVs with entrapped calcein were essentially prepared as
described above. The lipid ﬁlm was however hydrated in 50 mM
phosphate buffer, pH 7.4, containing 70 mM calcein (well above self-
quenching concentration). Non-entrapped calcein was separated
from the LUVs by gel ﬁltration on two consecutive Sephadex-G25
columns (Amersham Biosciences).
Two sets of leakage experiments were performed. First, the degree
of leakage was estimated as a function of peptide-to-lipid molar ratio
by titrating a LUV suspension of desired composition (total lipid
concentration was 100 μM) with small aliquots of peptide (from a
0.5 mM stock solution). Second, the time course of leakage was
monitored at a ﬁxed peptide-to-lipid (P/L) ratio (1:100) by
measuring the ﬂuorescence intensity as a function of time.
The degree of calcein leakage was estimated by measuring the
ﬂuorescence intensity from the released (unquenched) calcein as
described above. The maximum leakage level (100%) was established
by lysing the vesicles with 10% (v/v) Triton X-100 and the percent
leakage value was thereafter calculated according to:
%leakage = 100 ×
F−F0
Fmax−F0
 
ð2Þ
where F0 represents the background ﬂuorescence intensity of the
intact vesicles recorded prior to addition of peptide, F the measured
ﬂuorescence intensity after peptide addition, and Fmax the ﬂuores-
cence intensity of the lysed vesicle sample.
2.5. Calcein leakage induced by LL-37–Heparan sulphate complexes
LL-37 was mixed with heparan sulphate (HS) in molar ratios of
1:0, 1:1, 1:2, 1:4, 1:10 and 1:20. These solutions were added to
100 µM POPC:POPG (7:3) LUVswhich resulted in a ﬁnal concentration
of 4 µM LL-37 in all experiments. The release of calcein from the LUVs
was monitored at 37 °C.
2.6. DPH ﬂuorescence polarization
To monitor the bilayer perturbation caused by LL-37 interactions,
LUVs (at 200 µM lipid concentration) were doped with the mem-
brane-bound probe DPH (2 µM). The added DPH (from a 1 mM
ethanolic stock solution) was allowed to equilibrate in the mem-
branes for 15 min before measurement. LL-37 (P/L=0.1) was then
added to the DPH-doped LUVs and left to equilibrate for an additional
10 min. The polarization was calculated according to Eq. (1).
2.7. Circular dichroism (CD) spectroscopy
CD spectra were obtained with a Jasco J-720 Spectropolarimeter
equipped with a PTC-343 temperature controller. A quartz cell with
an optical path length of either 0.5 mm or 1.0 mm was used. The
spectral range was 190–250 nm with a resolution of 0.2 nm and a
bandwidth of 1.0 nm. A scan speed of 100 nm/min with 4 s response
time was employed. Spectra were collected and averaged over twenty
scans at a temperature of 20 °C unless stated otherwise. All spectra
were corrected for background contributions by subtraction of
appropriate blanks. To assess the secondary structure of LL-37 in the
presence of LUVs of different composition, 40 µM LL-37 was added to
a sample of LUVs (1 mM total phospholipid concentration). The
impact of temperature (0–60 °C) on the secondary structure of LL-37
(100 μM) in the absence of LUVs, was assessed in pure water.The population of the PPII helix (also called polyproline II or left-
handed 31 helix) was calculated from the CD amplitude of the
local maximum around 220 nm (the exact wavelength of this
maximum is dependent on the sequence). The population of the
left-handed PPII helix was estimated from the mean residual
ellipticities (MRE) at λmax using the relation published by Kelly
et al. [25].
PPII% =
½θmax + 6100
13;700
× 100% ð3Þ
2.8. Flow linear dichroism (LD) spectroscopy
LD was used to probe the orientation of the α-helical part of LL-37
when associated to POPC:POPG (7:3) LUVs. LD is deﬁned as the
difference in absorption of linearly polarized light oriented parallel
and perpendicular to the orientation axis of a sample, according to:
LD = AII−A⊥: ð4Þ
Macroscopic orientation can be obtained by subjecting LUVs to shear
ﬂow in a rotating Couette cell [26,27]. The shear forces render the LUVs
slightly ellipsoidal in shape and they will align with their long axes
parallel to the ﬂow direction. A peptide that binds to the membrane in
an ordered fashion will exhibit LD because its absorbing transition
moments display a preferential orientation. Transition moments that
are oriented preferentially parallel to the lipid vesicle surface display
positive LD and transition moments that are preferentially oriented
parallel to themembrane normal display negative LD. LL-37 contains no
aromatic residues and the only absorbing moieties are the amide
chromophores of the peptide backbone. In an α-helical peptide the
amide bond π→π* transitions interact by exciton coupling, which give
rise to two resultant transitions; one polarized parallel to the helix axis
(observed at 208–210 nm) and one polarized perpendicular to the helix
axis (observed at 190–195 nm). In addition, a weakly absorbing
(forbidden) n→π* transitionmay perhaps be observed at 220–225 nm.
LD spectra were recorded on a Jasco J-720 Spectropolarimeter
equipped with an Oxley prism to obtain linearly polarized light [28].
The samples were oriented in a Couette cell with a total path length of
1 mmusing a stationary shearﬂowof 3100 s−1. Spectrawere recorded
between 190 nm and 350 nm at room temperature. The scan speed
was 50 nm/min, the response time was 1 s, and the bandpass was
2 nm. 3 consecutive scans were collected and averaged by the
computer and all spectra were corrected for background contributions
by subtraction of the LD spectra recorded on the corresponding non-
oriented sample (i.e. without rotation of the Couette cell).
LD spectra were recorded only in POPC:POPG (7:3) LUVs at a
peptide-to-lipid molar ratio of approximately 0.02 and a total lipid
concentration of 2.2 mM. Samples were prepared in a 5 mM
phosphate buffer, pH 7.4 for maximum transparency in the far UV,
and supplemented with 50% (w/w) sucrose to reduce light scattering
and to increase the viscous drag and hence the degree of sample
orientation [26].
2.9. Confocal microscopy
Cells were seeded at low density in 4-well chamber slides and
allowed to adhere over night, and were then incubated with YOYO-1-
labeled DNA oligonucleotide and LL-37 according to the ﬁgure legend.
The cells were then cleared from unspeciﬁc extracellular ﬂuorophore
by brief rinsing with 1 M NaCl in PBS, followed by extensive rinsing
with PBS. Live cells were then visualized using a Nikon Eclipse E800
microscope and a Bio-Rad MRC 1024 confocal laser scanning
microscopy system. Collected data was analyzed using PC-compatible
Laser-Sharp software.
Fig. 2. LL-37 induced leakage of entrapped calcein from LUVs composed of POPC (-▲-),
POPC:POPG:Cholesterol (5:3:2) (-♦-), POPC:POPG (7:3) (-●-), and POPC:POPG (3:7)
(-■-) as a function of time. The peptide-to-lipid ratio was 0.01 and the total lipid
concentration was 100 μM. The experiments were performed at 20 °C.
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3.1. Leakage of entrapped calcein from LUVs
LUVs with various lipid compositions, mimicking fundamental
features of prokaryotic and eukaryotic membranes were prepared
with entrapped calcein. Fig. 1 shows the level of induced calcein
leakage obtained by titrating incremental amounts of LL-37 to a
suspension of LUVs. Each data point was recorded after 5 min
incubation at 20 °C. The ﬁgure shows that neutral POPC LUVs remain
intact even up to a P/L molar ratio of 0.05 which is extremely high
from a physiological perspective. In contrast, considerable calcein
leakage was induced in the two examined types of net negatively
charged POPC:POPG LUVs. Increasing the amount of POPG in these
LUVs from 30 to 70% increased the leakage efﬁciency to some extent,
which may be explained by increased electrostatic interactions.
Nearly 100% leakage is obtained for POPC:POPG (3:7) LUVs, indicating
massive disruption of the lipid bilayer in this particular case. These
results suggest that LL-37 behaves as a classic AMP, completely
discriminating between neutral (host-like) and negatively charged
(target-like) membranes. This is in contrast to what was previously
reported by Oren et al. [3] who reported leakage of small monovalent
cations (potassium) in both types of membranes. A potential
explanation to this discrepancy is that calcein is a considerably larger
molecule than potassium and thus may require more severe
disruptions of the LUV membrane in order to escape.
Fig. 2 shows the time course of leakagemonitored at a constant P/L
of 0.01. The calcein leakage curves are biphasic, with faster kinetics for
LUVs with higher negative charge. This two-phase leakage kinetics
behavior with an apparent plateau, has been observed for many
peptides that induce membrane leakage [29,30]. The observation of a
leakage plateau can be described as due to a relaxation process by
which the membrane rearranges after the peptide is added, a so-
called graded leakage mechanism [23,31]. It should be noted that the
ﬂow linear dichroism signal of the peptide presented in Fig. 5
increases on a similar timescale (minutes-hours) as the relaxation
observed in the leakage (vide infra), suggesting that we indeed can
observe the slow process by which the bound peptide and/or the
surrounding lipids, approach an equilibrium state. Calcein leakage is
counteracted by the presence of cholesterol in the phospholipid
bilayer, as observed by the addition of 20% cholesterol (on expense of
POPC) to the LUVs containing 30% negative charge (Fig. 2). This is in
agreement with the results by Sood et al. [13,19] and furthers the
evidence for LL-37's classical AMP behavior.
Calcein leakage induced by LL-37 in partly charged LUVs is not
signiﬁcantly affected by incubation temperature (4, 20 and 37 °C, dataFig. 1. LL-37 induced leakage of entrapped calcein from LUVs composed of POPC (-▲-),
POPC:POPG (7:3) (-●-), or POPC:POPG (3:7) (-■-) as a function of peptide-to-lipid
molar ratio, [peptide]/[lipid]. Data was collected while titrating LUVs with increasing
amounts of peptide. The samples were incubated for 5 min prior to measurement and
further addition of peptide. The total lipid concentration was 100 μM and the
experiments were performed at 20 °C.not shown). We next investigated to what extent binding to heparan
sulphate (HS), i.e. a highly polyanionic polysaccharide covering the
surface of eukaryotic cells while absent on prokaryotes, could
diminish LL-37-induced calcein leakage from POPC:POPG (7:3)
LUVs. LL-37 was pre-incubated with fractions of HS at up to 10
times the stoichiometric ratio and the mixture was thereafter added
to the LUVs at 20 °C. Despite HS being strongly negatively charged and
thus potentially prone to electrostatically interact with cationic LL-37,
only minor effects on the induced calcein leakage were found
(Supplementary information, Table S1).
3.2. Secondary structures of LL-37
Initial CD studies showed LL-37 to be mainly in a random coil
conformation at 20 °C in water, in agreement with previous observa-
tions [12]. However, the CD spectra of LL-37 in pure water revealed a
temperature-dependent equilibrium between a left-handed PPII helix
and a disordered random coil secondary structure, which dominates
at higher temperatures (Fig. 3). The population of the left-handed PPII
helix, as calculated according to Eq. (3), changed from 39% to 17%
when the temperature was increased from 0 °C to 60 °C. A similar
behavior has been observed previously with other peptides of similar
length, e.g. the negatively charged amyloid Aβ(1–40) peptide
involved in Alzheimer's disease [32]. The temperature-dependent
ability to form a PPII helix provides an explanation to why the Aβ
peptide is best soluble at low temperature, where the PPII helix favors
hydrogen bonding interactions between peptide backbone atoms and
the aqueous solvent [33]. The current data indicates that LL-37Fig. 3. CD spectra of LL-37 (100 μM) in distilled water as a function of temperature.
Spectra were recorded in 10 °C intervals ranging from 0 to 60 °C (the initial and ﬁnal
spectra are marked in bold). The population of left-handed PPII helix decreased as the
temperature and population of random coil increased.
Fig. 5. Linear dichroism (LD) spectra of LL-37 bound to POPC:POPG (7:3) LUVs recorded
immediately after mixing (a) and after 1 h incubation at ambient temperature (b). The
peptide-to-lipid molar ratio was approximately 0.02. The positive LD peak at 208 nm
shows that the α-helical part of LL-37 is oriented in parallel to the membrane surface.
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larly interesting in the light of the suggestions that LL-37 [3,19], like
the Aβ peptide [34], may exert its membrane perturbing activity via
the formation of cytotoxic oligomeric assemblies.
We next attempted to mimic the effect of eukaryotic cell-surface
associated HS on the secondary structure of LL-37, by adding water-
soluble fractions of HS to a peptide solution. Additions of HS in
amounts up to twice the weight concentration of LL-37 did not
signiﬁcantly change the random coil CD spectrum of the peptide,
indicating lack of speciﬁc interactions inducing secondary structure
(Supplementary information, Fig. S1). In experiments with ﬂuores-
cently labeled HS we could however observe LL-37-induced ﬂuores-
cence quenching (data not shown), suggesting that LL-37 and HS
indeed form complexes, although this is only weakly manifested in
secondary structure and calcein leakage induction.
The CD spectra of LL-37 in the presence of POPC and POPC:POPG
(3:7) LUVs at 20 °C are shown as Fig. 4. LL-37 in the presence of POPC
generates a CD spectrum clearly different from that of a random coil/
PPII spectrum (Fig. 3). The spectral shape suggests a weakly forming
secondary structure, possibly a distorted α-helix. In complex with the
partly negatively charged LUVs (POPC:POPG (3:7)) LL-37 adopts a
dominant α-helical structure, evidenced by the shape of its CD
spectrum (Fig. 4). Thus, in the presence of negatively charged
membranes, LL-37 behaves as a typical amphipathic peptide.
3.3. LL-37 orientation in POPC:POPG (7:3) membranes
Under conditions where LL-37 forms a partialα-helix when bound
to lipid membranes, it is possible to use ﬂow LD spectroscopy to
investigate the orientation of the peptide α-helix with respect to the
lipid bilayer. Fig. 5 shows LD spectra of LL-37 in shear-oriented POPC:
POPG (7:3) LUVs recorded immediately upon addition of peptide to a
suspension of LUVs, and after 1 h incubation. The positive LD centered
at 210 nm arises from the amide π→π* transitions of the peptide
bond. In an α-helix these interact by exciton coupling and give rise to
two transitions: one at a longer wavelength ∼208 nm (polarized
parallel to the helix axis), and one at a shorter wavelength ∼195 nm
(polarized perpendicular to the helix axis). The positive signature of
the peak in the LD spectra shown in Fig. 5 therefore indicates that the
α-helical part of LL-37 is on the average oriented parallel to the
membrane surface, in agreement with previous studies using
polarized ATR-FTIR and solid-state NMR [3]. The peptide bond
n→π* transitions are orthogonal to the π→π* transitions and should
in principle appear as a negative peak at 220–225 nm. This cannot be
observed in Fig. 5, thus conﬁrming the weak nature of these
transitions compared to the π→π*. In addition, we observed a
signiﬁcant increase in the LD signal on a time scale of about an hourFig. 4. CD spectra of LL-37 recorded in the presence of (a) POPC and (b) POPC:POPG
(3:7) LUVs at 20 °C. The peptide concentration was 40 μM and the lipid concentration
was 1 mM.(Fig. 5), which indicates that the peptide, and/or the lipid vesicle
membrane, obtains a higher degree of order. This rearrangement
occurs on the same time scale as the calcein leakage builds up and
reaches a maximum plateau, suggesting that these processes may be
related.
3.4. DPH polarization
The effect of LL-37 on the membrane order/ﬂuidity was studied
using LUVs of varying membrane compositions (in terms of POPC,
POPG and cholesterol), labeled with the ﬂuorescent probe DPH (1,6-
diphenyl-1,3,5-hexatriene). DPH intercalates into lipid bilayers and its
excited state is sensitive to the rigidity of its surroundings. Therefore,
ﬂuorescence polarization (and anisotropy) can be used to monitor
changes in membrane order upon addition of ligands to a lipid bilayer.
Table 1 shows the ﬂuorescence polarization from DPH in LUVs of
different compositions with or without LL-37 at the P/L ratio of 0.10.
The experiments were repeated 4 times for each condition, and an
experimental uncertainty was estimated. As expected, the differences
in DPH polarization without and with peptide are relatively small.
However, for the negatively charged LUVs it is apparent that there is
an increase in the DPH polarization, and hence a decrease in
membrane ﬂuidity, when the peptide is added.
3.5. LL-37 mediated delivery of DNA oligonucleotide into eukaryotic cells
Fig. 6, lower panels, show confocal microscopy images of a
ﬂuorophore-labeled, 21-mer DNA oligonucleotide inside live COS-7
cells after delivery as non-covalent complexes with LL-37. The
composition of the complex is about 1/1 peptide/DNA basepair, i.e.
generating complexes where the positive charge provided by the
peptide is in excess of the negative charge provided by the phosphateTable 1
Changes in steady-state ﬂuorescence polarization of DPH (incorporated into LUVs of
different compositions) upon addition of LL-37. The lipids were either pure POPC or
POPC/POPG or POPC/POPG/cholesterol at the indicated ratios. The total lipid
concentration was 200 μM and the LUVs were pre-incubated with 2 μM DPH for
10 min. P/L is the peptide-to-lipid molar ratio and ΔP is the change in polarization after
addition of the peptide. The temperature was 37 °C. All measurements were repeated 4
times and an average uncertainty (standard deviation) is indicated.
P/L POPC POPC/POPG
(7/3)
POPC/POPG
(3/7)
POPC/POPG/Chol
(5/3/2)
0 0.185±0.012 0.139±0.007 0.146±0.002 0.186±0.001
0.1 0.165±0.014 0.162±0.015 0.212±0.010 0.207±0.007
ΔP −0.020 +0.023 +0.056 +0.021
Fig. 6. Confocal microscopy images of live COS-7 cells incubated with YOYO-1-labeled DNA oligonucleotide complexedwith LL-37 peptide (20 μM) for 4 h (lower left panel) and 24 h
(lower right panel). Upper left and right panels show the corresponding control experiments in the absence of LL-37. In the presence of LL-37 the punctuate staining indicates
vesicular uptake of the complexes. Also at the later time point (lower right panel) the DNA oligonucleotide distribution remains mainly vesicular, indicating limited vesicular escape.
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insigniﬁcant under similar conditions, as seen in the upper panels of
Fig. 6. The distinct, punctuate ﬂuorescence signal at 4 h of LL-37–DNA
complex incubation (Fig. 6, lower left panel) suggests endocytosis as
the major pathway of membrane translocation, and that general
cytoplasmic delivery (endosomal escape) is not very efﬁcient. The
escape of endocytosed cargo molecules should occur before the
endosome has developed into/fused with a lysosome if the cargo is to
be delivered intact to the cytoplasm. After 24 h of incubation (Fig. 6,
lower right panel), the distribution of internalized DNA appears as
more diffuse, which together with nuclear localization suggests some
leakage of DNA oligonucleotides from endocytic vesicles.
4. Discussion
The present results of LL-37 interaction with model membranes
give an unambiguous picture of its discrimination between zwitter-
ionic and negatively charged membranes in systematically varied and
well deﬁned lipid LUV model systems. The zwitterionic membranes
are not rendered permeable for the enclosed relatively large calcein
molecules, whereas the partly negatively charged membranes are
affected in relative proportion to the degree of headgroup charges
(Figs. 1 and 2). The leakage results extend previous observations using
LUVs of other compositions [19]. For the negatively charged
membranes, the addition of peptide decreases the membrane ﬂuidity
(Table 1).
The calcein leakage from partly negatively charged LUVs occurs by
a so-called graded mechanism observed on a min h time scale (Fig. 2).The orientation of LL-37 in the membrane is predominantly with the
axis of its induced α-helix parallel to the lipid bilayer surface, as
concluded from the linear dichroism (LD) of the amide chromophores
in the peptide (Fig. 5), and which is in agreement with previous
studies using other methods and membrane preparations [3,18].
Interestingly, we could observe how the LD of these transitions
increased on the same timescale as the peptide-induced calcein
leakage reached a plateau in Fig. 2. This indicates that we can probe
changes in the peptide orientation (or in the lipid environment
around the peptide) leading to a “healing” or return of membrane
integrity. In a more detailed model of membrane leakage, the
observed increase in LD could be connected to a peptide translocation
step and an establishment of a ﬁnal mass balance across the
membrane, which should end the calcein leakage according to the
model of graded release [29].
Glycosaminoglycans in biological ﬂuids efﬁciently inhibit the
antibacterial effects of LL-37 [35] and cell-surface proteoglycans are
necessary for LL-37-mediated uptake of plasmid DNA [24]. It was
therefore a somewhat surprising result in our model system studies
that HS, a major polyanionic polysaccharide speciﬁcally found on the
surface of eukaryotic cells, only weakly affected the leakage-inducing
activity (Table S1) and the random coil CD spectrum of LL-37 (Fig. S1).
However, the ﬂuorescence quenching experiments revealed LL-37–
HS complex formation, as would be expected from the electrostatic
interactions. Obviously the proteoglycan interaction, as it is modeled
in the present system, is not strong enough to signiﬁcantly affect
neither the secondary structure nor the leakage induction activity of
LL-37. These data suggest that the relative resistance of eukaryotic
2207X. Zhang et al. / Biochimica et Biophysica Acta 1798 (2010) 2201–2208cells to the cytotoxic effect of LL-37 is not only explained by their
overall expression of HS, but also by their membrane architecture and
composition, particularly the presence/absence of charged head-
groups. In further support of this notion, in a cell viability assay HS-
deﬁcient cells did not respond differently to LL-37 peptide treatment
as compared with HS-expressing wild-type cells (S. Sandgren and
M. Belting, unpublished observation).
The CPP property of LL-37 is shown by its ability to mediate
delivery of a non-covalent complex with a ﬂuorescently labeled
oligonucleotide into eukaryotic cells (Fig. 6). These results are in
agreement with previous experiments showing LL-37 mediated
delivery of plasmid DNA into mammalian cells [24]. Recent studies
also show that LL-37 forms large aggregated complexes with released
“self-DNA” and delivers DNA into dendritic cells, thereby triggering an
autoimmune response linked to psoriasis [8]. The present results
highlight the potential secondary role of LL-37 as a mediator of cell
delivery of nucleic acids (or possibly other negatively charged
molecules or assemblies). The confocal micrographs in Fig. 6 show
that the intracellular localization of LL-37–DNA complexes is vesicular
with only minor leakage of DNA oligonucleotide into the cytosol/
nuclear compartment, indicating that endocytosis, possibly macro-
pinocytosis [36], is the mechanism of cargo delivery into the cells. The
LL-37-mediated cell delivery is similar to that reported for ﬂuorescent
analogues of the antimicrobial peptides magainin and buforin (of frog
and toad origin, respectively), although the detailed cell translocation
mechanisms may differ and also depend on variables such as cell type
and presence and nature of cargo [37]. Previous studies [24] have
shown that LL-37 is not cytotoxic to eukaryotic cells in concentrations
up to 10 μM, whereas E. coli cells are killed at concentrations below
3 μM. The results presented here, where the concentration of LL-37 in
Fig. 6 is 20 μM without any drastic effects on the cell images, suggest
that the CPP activity of LL-37 on eukaryotic cells is valid up to quite
high concentrations, compared to the concentrations required for the
antimicrobial activity on bacterial cells.
In conclusion, our results are in agreement with a straightforward
model of the effect of LL-37 on negatively charged bacterial target
membranes: It binds to the membrane surface, whereupon α-helical
structure is induced with the helix axis parallel to the membrane
surface. At a relatively high peptide concentration (micromolar, with
P/L 0.05) themembrane is made leaky which shouldmodel toxicity in
a biological system. Under similar conditions, a zwitterionic mem-
brane, representing a eukaryotic host cell, is not made leaky by LL-37.
However, when LL-37 acts on the real membranes of eukaryotic cells
together with external DNA, it is able to mediate transfer of the DNA
into the cells, thereby demonstrating its activity as a CPP, possibly
acting by a biological endocytotic mechanism rather than by direct
membrane penetration.
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